Abstract：
OBJECTIVE: To assess reporting guideline and clinical trial registration requirements in rehabilitation journals.
METHODS: We examined rehabilitation journals with 5-year impact factors exceeding 1.00 from the 2021 Scopus CiteScore tool, alongside the 28 journals included in the 2014 rehabilitation and disability quality improvement initiative. Journals outside the traditional rehabilitation scope were excluded.
METHODS: A publicly-funded academic health center in the United States.
METHODS: N/A.
METHODS: The proportion of journals requiring/recommending reporting guideline use and clinical trial registration.
RESULTS: Over 90% (57/63) of journals required/recommended clinical trial reporting guidelines, while 68% (39/57) specified guideline requirements for systematic review/meta-analysis protocols. The 2014 collaborative initiative journals demonstrated higher rates of requiring/recommending reporting guidelines for clinical trials (24/26; 92.3%), systematic reviews/meta-analyses (23/26; 88.5%), observational studies in epidemiology (22/25; 88%), and diagnostic accuracy studies (20/24; 83.3%). Conversely, the 2021 Scopus CiteScore journals displayed higher rates for the remaining study designs. Overall, 52/63 (82.5%) journals required/recommended trial registration. Trial registration policies were comparable, with a slight advantage favoring the 2021 Scopus CiteScore journals.
CONCLUSIONS: Rehabilitation journals variably promoted reporting guideline use and clinical trial registration. Common study designs like clinical trials, observational studies in epidemiology, and diagnostic accuracy studies demonstrated robust requirement/recommendation rates, while less common designs like economic evaluations and animal research had suboptimal rates. Journals can enhance reporting guideline use and trial registration by directing authors to the EQUATOR Network, requiring adherence to registration and reporting standards, and clarifying language in author instructions.
METHODS: We examined rehabilitation journals with 5-year impact factors exceeding 1.00 from the 2021 Scopus CiteScore tool, alongside the 28 journals included in the 2014 rehabilitation and disability quality improvement initiative. Journals outside the traditional rehabilitation scope were excluded.
METHODS: A publicly-funded academic health center in the United States.
METHODS: N/A.
METHODS: The proportion of journals requiring/recommending reporting guideline use and clinical trial registration.
RESULTS: Over 90% (57/63) of journals required/recommended clinical trial reporting guidelines, while 68% (39/57) specified guideline requirements for systematic review/meta-analysis protocols. The 2014 collaborative initiative journals demonstrated higher rates of requiring/recommending reporting guidelines for clinical trials (24/26; 92.3%), systematic reviews/meta-analyses (23/26; 88.5%), observational studies in epidemiology (22/25; 88%), and diagnostic accuracy studies (20/24; 83.3%). Conversely, the 2021 Scopus CiteScore journals displayed higher rates for the remaining study designs. Overall, 52/63 (82.5%) journals required/recommended trial registration. Trial registration policies were comparable, with a slight advantage favoring the 2021 Scopus CiteScore journals.
CONCLUSIONS: Rehabilitation journals variably promoted reporting guideline use and clinical trial registration. Common study designs like clinical trials, observational studies in epidemiology, and diagnostic accuracy studies demonstrated robust requirement/recommendation rates, while less common designs like economic evaluations and animal research had suboptimal rates. Journals can enhance reporting guideline use and trial registration by directing authors to the EQUATOR Network, requiring adherence to registration and reporting standards, and clarifying language in author instructions.
摘要：
目的：评估康复期刊的报告指南和临床试验注册要求。
方法：我们从2021年ScopusCiteScore工具中检查了五年影响因子超过1.00的康复期刊，与2014年康复和残疾质量改善计划中包含的28种期刊一起。传统康复范围之外的期刊被排除在外。
方法：美国公共资助的学术健康中心。
方法：不适用主要结果指标：要求/推荐报告指南使用和临床试验注册的期刊比例。
结果：超过90％（57/63）的期刊要求/推荐的临床试验报告指南，而68%(39/57)规定了系统评价/荟萃分析方案的指南要求。2014年的合作倡议期刊显示出更高的要求/推荐临床试验报告指南的比率（24/26;92.3％），系统评价/荟萃分析（23/26；88.5%），流行病学观察性研究(22/25；88%)，和诊断准确性研究（20/24；83.3%）。相反，2021年ScopusCiteScore期刊在其余研究设计中显示出较高的比率。总的来说,52/63（82.5%）期刊要求/建议试用注册。试用注册政策具有可比性，略有优势，有利于2021年ScopusCiteScore期刊。
结论：康复杂志不断促进报告指南使用和临床试验注册。常见的研究设计，如临床试验，流行病学观察性研究，诊断准确性研究证明了强劲的需求/推荐率，而较不常见的设计，如经济评估和动物研究，却有次优率。期刊可以通过将作者引导到EQUATOR网络来增强报告指南的使用和试验注册，要求遵守注册和报告标准，并在作者说明中澄清语言。
方法：我们从2021年ScopusCiteScore工具中检查了五年影响因子超过1.00的康复期刊，与2014年康复和残疾质量改善计划中包含的28种期刊一起。传统康复范围之外的期刊被排除在外。
方法：美国公共资助的学术健康中心。
方法：不适用主要结果指标：要求/推荐报告指南使用和临床试验注册的期刊比例。
结果：超过90％（57/63）的期刊要求/推荐的临床试验报告指南，而68%(39/57)规定了系统评价/荟萃分析方案的指南要求。2014年的合作倡议期刊显示出更高的要求/推荐临床试验报告指南的比率（24/26;92.3％），系统评价/荟萃分析（23/26；88.5%），流行病学观察性研究(22/25；88%)，和诊断准确性研究（20/24；83.3%）。相反，2021年ScopusCiteScore期刊在其余研究设计中显示出较高的比率。总的来说,52/63（82.5%）期刊要求/建议试用注册。试用注册政策具有可比性，略有优势，有利于2021年ScopusCiteScore期刊。
结论：康复杂志不断促进报告指南使用和临床试验注册。常见的研究设计，如临床试验，流行病学观察性研究，诊断准确性研究证明了强劲的需求/推荐率，而较不常见的设计，如经济评估和动物研究，却有次优率。期刊可以通过将作者引导到EQUATOR网络来增强报告指南的使用和试验注册，要求遵守注册和报告标准，并在作者说明中澄清语言。
